The $2.2-million drug discovery partnership with the B.C.-based biotech company will explore using diverse fungi for medicinal purposes, and will facilitate the large-scale production of any leads.
Wright, a professor in the Department of Biochemistry and Biomedical Sciences, has been recognized for his internationally-renowned research in antimicrobial resistance.
McMaster University is working with the infectious disease team at the Chan Zuckerberg Initiative (CZI) to improve access to antimicrobial resistance (AMR) data, so scientists across the world can better prevent global health threats.